Auriga Partners
Venture capitalParis · Seed–Growth · 15 people tracked
Find your way into Auriga Partners
1,293 people in our graph share verified history with the Auriga Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Auriga Partners is a pioneer of venture capital in France that has reinvented itself as a multi-specialist investor aiming to bring together specific expertise around forward-looking themes and territories, investing in both private and public companies. The firm supports entrepreneurs at every stage of their development, from creation through to exit via trade sale or IPO. It emphasizes the power of innovation—whether in usage or disruptive—to catalyze positive change for lives and societies, and leverages collective intelligence built from federating talent and expertise across future-oriented themes.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website & public directories
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Deep Tech ×1Digital Health ×1Medical Devices ×1
HQs:France×1United States×1
Investments · 2 tracked
founders shown can be your intro path
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis).
BiotechDeep TechDigital HealthMedical DevicesParis, FR
Harry Sokol(Scientific Co-founder)in
Co-investorsBpifranceAgoranovForepont Capital PartnersUI Investissement
Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.
BiotechCambridge, US
Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)inMichael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)
Co-investorsCycad Group LLCLux CapitalMC Healthcare VenturesAdvent Life SciencesAlexandriaBill & Melinda Gates Foundation+1 more
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does Auriga Partners invest at?
- Auriga Partners invests at the Seed, Series A, Series B, Growth stages.
- What is Auriga Partners's typical check size?
- Auriga Partners typically writes checks of $540K – $5.4M.
- What sectors does Auriga Partners focus on?
- Auriga Partners focuses on Biotech, Consumer, Cybersecurity, Data & Infrastructure, Enterprise Software, Hardware, Healthtech, Longevity, Medical Devices, New Materials, SaaS, Sector Agnostic.
- Where is Auriga Partners located?
- Auriga Partners is headquartered in Paris, FR.
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.